CareLit · DOI-Nachweis · Pneumologie
Effects of long term ToBrAmycin InhalaTion SoluTion (TIS) once daiLy on Exacerbation rate in patients with non-cystic fibrosis bronchiectasis. A doubleblind, randomized, placebo controlled trial. The BATTLE study.
DOI 10.1055/s-0036-1592239
Bibliografische Angaben
Nachweis in CareLit
Autor:innenL Terpstra, J Altenburg, W Boersma
ZeitschriftPneumologie
Ausgabe10/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Rationale: Patients with bronchiectasis often have exacerbations of their disease. These exacerbations influence the quality of life. In patients with cystic fibrosis (CF) inhaled antibiotics lower the bacterial load in bronchial secretions and have a positive effect on the number of exacerbations, lung function and quality of life (QoL). In patients with non-CF bronchiectasis colonized with Pseudomonas aeruginosa,…
Zitieren
Zitierempfehlung
L Terpstra, J Altenburg, W Boersma (2016) Effects of long term ToBrAmycin InhalaTion SoluTion (TIS) once daiLy on Exacerbation rate in patients with non-cystic fibrosis bronchiectasis. A doubleblind, randomized, placebo controlled trial. The BATTLE study. Pneumologie (10). https://doi.org/10.1055/s-0036-1592239
Mit CareLit weiterarbeiten